A new comprehensive plan to speed and enhance HIV vaccine research was published in Nature Medicine.

Alan Bernstein and Peter Piot
The Globe and Mail (Canada)
Tuesday, August 10 2010

http://www.theglobeandmail.com/news/opinions/hiv-is-a-20th-century-disease-that-needs-21st-century-research/article1667175/

We need smarter approaches to clinical trials that test more concepts in less time, for less money, while preserving safety, community engagement and ethical guidelines.

The Enterprise hosted and participated in a handful of activities at AIDS 2010.  A summary of the meeting is posted below.

The Enterprise and the New York Academy of Sciences hosted a symposium that brought together HIV vaccine researchers to discuss the latest developments in the field. The meeting summary is below.

The Global HIV Vaccine Enterprise and the New York Academy of Sciences will present HIV/AIDS: Vaccines and Alternate Strategies for Treatment and Prevention, a daylong meeting at the New York Academy of Sciences on May 19, 2010.

The OCTAVE Project (Online Collaborative Training for AIDS Vaccine Evaluation) and the Global HIV Vaccine Enterprise, in collaboration with AVAC: Global Advocacy for HIV Prevention and UNAIDS, are organizing an interactive workshop for Young and Early Career Investigators (YECIs). This workshop will focus on the process to engage community stakeholders in planning and conducting HIV biomedical prevention research.

IAVI and biotechnology company, Lentigen Corporation, announced a collaboration to design a preventive AIDS vaccine based on Lentigen's technology.

Steady advances are being made in the search for an HIV/AIDS vaccine, according to a new overview of research presented at the AIDS Vaccine 2009 Conference published in the May 2010 edition of The Lancet Infectious Diseases.

The Enterprise Council met on 7 April 2010.  Minutes from the meeting are below.